Liver Cancer News
2023
December 2023
Combination Immunotherapy in Low Tumor Burden HCC
Hong Kong: Researchers Claim World's First With Liver Cancer Treatment
'Miracle' Treatment That Reduces Late-Stage Liver Cancer Developed, Claim Hong Kong Researchers
Novel Insights Into HBV-hepatocellular Carcinoma At Single-Cell Sequencing
Study Examines Population Risks Associated With Liver Cancer
Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial
Short MRI Protocol Effective For Assessing Liver Cancer Treatment
Mayo Clinic Minute: Treating Liver Cancer
Cancer Discovery: How the Liver Defends Itself
Atezolizumab plus Bevacizumab in the Treatment of Unresectable HCC
The Evolving Landscape of Hepatocellular Carcinoma
NiKang Partners With Roche On Liver Cancer Drug Study
Dr. Gholam on Camrelizumab Plus Rivoceranib in Unresectable HCC
Early Signs Of Liver Damage You Should Not Ignore
Addressing the Treatment Gap: Improving Antiviral Therapy for HCV-Related Hepatocellular Carcinoma
Fewer Cases of HCC Were Diagnosed in the First Year of the COVID-19 Pandemic
Gene Therapy Shrinks Liver Cancer in Mice
November 2023
Scientists Find Gene Therapy Reduces Liver Cancer In Animal Model
Enhanced Treatment Of Liver Carcinoma With A Drug-Eluting Hydrogel
Morphology-Based Gross Classification System For Hepatocellular Carcinoma Stratification
Primary Liver Cancer: Causes, Symptoms And Risk Factors Of This Tumour
Advancements in Liver Cancer Treatment Brings Hope for Black Patients
Can-Fite (CANF) Up on Liver Cancer Study Update of Namodenoson
Direct-Acting Antivirals Still Underused in Hep C-Related Liver Cancer
Increasing Generational Status Linked to Elevated Risk for Liver Cancer
Robotic Device May ‘Level the Playing Field’ in Liver Cancer Surgery
AstraZeneca Shares Positive Phase 3 Results For Imfinzi Combination In Liver Cancer
Innovative Treatment Uses Radio Frequency To Target And Reduce Cancerous Tumors
Researchers Look To Improve Early Identification Of Liver Cancer
Pioneering Histotripsy Device Receives FDA Clearance To Treat Liver Cancer
Hepatitis C Treatment Improves Liver Cancer Survival
Karmanos Cancer Institute First To Receive New Fda-Approved Treatment For Advanced Liver Cancer
Durvalumab Regimen Extends PFS in Certain Patients with Liver Cancer
Mash Now Top Indication For Liver Transplantation In Those With Hepatocellular Carcinoma
History of Hepatocellular Carcinoma Increases Risk of Liver-Related Mortality After SVR
Can Non-Alcoholic Fatty Liver Trigger Liver Cancer And Failure?
Features Found On MRI May Predict Liver Cancer Recurrence After Surgery
Surgeons To Get A High-Tech Assistant: Smartphone App For Assessing Liver Surgery Risks
Potential New Targets For Chronic Liver Disease
Time-to-Response Correlation to HCC Treatment Effectiveness and Patient Prognosis
Proving The Efficacy Of Local Treatment In Liver Cancer Oligometastases
Liver Regeneration: How The Liver’s Ability To Recover Plays Into Liver Cancer Surgery
Liver Cancer Awareness: The Importance of Early Diagnosis and Screening
Unlocking the Potential: CRISPR-Cas9 Gene Editing in Liver Diseases
ESMO 2023: Current Research on Advanced and Progressing Hepatocellular Carcinoma
October 2023
Doctor Says Liver Cancer Diagnosis, Transplant Gave New Perspective
The Future of Liver Function Assessments in HCC
Abdominal Fat CT Radiomics Help Predict Liver Cancer Recurrence
Liver Cancer 'Being Missed' Prompting Calls For Better Surveillance
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular Carcinoma
NHS Roaming Trucks Identify Over 2000 People At Risk Of Liver Cancer
Discussing Treatment Options for Patients With HCC
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA
Resistance To Liver Cancer Treatment Discovered By UH Researchers
Protect Your Liver: How To Prevent, Get Tested For, And Treat Hepatitis B And C Infection
Liver Cancer Awareness Month: Understanding and Treating HCC
Understanding Patient Perspectives During Liver Cancer Awareness Month
Tissue Biopsy Holds Its Place as the Golden Standard in HCC
Hepatocellular Carcinoma Surveillance In Australia: Current And Future Perspectives
Tislelizumab vs Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma
GLS2 Shapes Ferroptosis In Hepatocellular Carcinoma
Liver Cancer Declined After Advent of Hepatitis C Treatment
Sound Waves Treatment to Blast Liver Tumors Gains FDA Approval
Data Show New Treatment Options for Patients With Liver Cancer May Be on the Horizon
American Liver Foundation Hosts Free Liver Cancer Conference for Patients and Families
Dr. Christopher Lieu On The Next Frontier of Liver Cancer Therapy
What To Know About Liver Cancer
At The ‘Extreme Edge’ Of Transplant Possibility, VCU Health Says ‘Yes’ To Liver Cancer Patient
Tislelizumab Has Comparable Outcomes to Nexavar in Liver Cancer Subset
#OctoberIs4Livers Campaign Aims To ‘Turn The Tide’ During Liver Cancer Awareness Month
Antidepressant Use After Diagnosis May Reduce Liver Cancer Mortality
Adding a Novel Agent to Standard of Care May Improve Survival in Liver Cancer
TPST-1120 Combo Yields Positive Activity in Hepatocellular Carcinoma
Tislelizumab Could Be a First-Line Treatment for HCC
Antidepressants After Diagnosis of Liver Cancer May Lower Mortality Rates
A Promising First-line Treatment for Unresectable Hepatocellular Carcinoma
Assessing Liver Function in Patients With HCC: The ALBI Score
Research To Detect Liver Cancer
Assessing Liver Function in Patients With HCC: The Child-Pugh Score
FDS Approves The Use Of Sound Waves To Break Down Tumors In Humans For Liver Treatment
Risk Factors of Hepatocellular Carcinoma (HCC)
OTX-2002 Shows Encouraging Safety in Small Hepatocellular Carcinoma Cohort
Importance of Assessing Liver Function in HCC
Health Experts Outline Subtle Signs Of Liver Cancer And Symptoms To Look Out For
Subtle Signs Of Liver Cancer And How To Avoid Everyday Causes Of 'Silent Killer'
Liver Cancer and Its Connection to Alcohol Use
Global Communities Rally Around Third Deadliest Cancer – Liver Cancer
Doctors’ Debate: Frontline Targeted Therapies Inform Treatment Decisions in HCC
Dr. Biachi on the Growing Treatment Landscape in HCC
September 2023
Choosing the Optimal First-Line Regimen for Patients With Advanced HCC
What Will Be the Next Frontline Therapy for HCC?
Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment
First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma
Cabozantinib Is Safe and Tolerable in Sorafenib-Intolerant HCC
First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma
DNA/RNA Sequencing Aids Subsequent Treatment Selection in HCC/H-CCK Post Atezolizumab/Bevacizumab
Primary Liver Cancer Treatment Discovery Unveiled
Indian Study Shows New Drug Combination Promising For Liver Cancer Patients
New Discovery For Treatment Of Primary Liver Cancer Shows Promise In Mice
Q&A: Causes Of Hepatocellular Carcinoma ‘Differ Remarkably’ By Race, Ethnicity
Vaxcell-Bio Back On Track With Positive Liver Cancer Clinical Progress, Capital Increase
Real-World Analysis Highlights US Treatment Patterns for Frontline Atezolizumab/Bevacizumab in HCC
Data for Second-Line or Later Ramucirumab Show Consistent Benefit in Advanced HCC
Addressing the Unique HCC Treatment Landscape With Fostrox
The Unusual Liver Cancer Symptom You Can Spot When Carrying Shopping
Fonkoua Sheds Light on Liver Cancer Clinical Trial Disparities
Race, Ethnicity Variances May Cause Liver Cancer: Study
Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
New Study Suggests Race and Ethnicity Play a Role in Liver Cancer
Fostrox Plus Lenvatinib Shows Encouraging Results in HCC
Medivir Announces Interim Data From HCC Combined Therapy Study
August 2023
Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC
Liver Cancer Causes Highest Death Among Cancers in Việt Nam
CEUS with Perfluorobutane Improves HCC Diagnosis
Dr. Jihane Benhammou Receives Grant from Veterans Affairs Research
Survival “Excellent” for Patients With Infection Before Liver Transplant
Hepatitis B and C Viruses Can Lead to Liver Cancer: Health Experts Reveal How
Douglas Shaw: Liver Cancer Survivor
Keck School of Medicine Researchers Receive $12 million Grant to Study Early Liver Transplantation
Gene Therapy Study Identifies Potential New Treatment for Liver Cancer
UCSD Gets $9.57M Grant to Study New Treatment for Liver Disease
Future of Advanced HCC Treatment
Calculator Predicts Benefit of Chemoembolization for Liver Cancer
Personalized Neoantigen Vaccine Induces Continued Responses in Pretreated, Advanced HCC
Nanoparticle Research by URI Prof Aims to Prevent, Treat Cancers
Proton Beam Radiotherapy as Treatment Alternative to TACE for Patients With Hepatocellular Carcinoma
Q&A: Assessing Current Evidence & Approaches for Treating HCC
Sintilimab Plus Bevacizumab Biosimilar vs Avastin Is Cost-Effective in HCC
Medivir Partners with World-leading Liver Cancer Experts in New Scientific Advisory Council
Statin Use Associated With Decreased Liver Disease, Mortality
The New Van Bringing Liver Cancer Checks to People's Doorsteps
Camrelizumab Plus Rivoceranib vs Sorafenib in Unresectable Hepatocellular Carcinoma
UCLA Study Finds New Way to Protect Livers During Transplantation
Three Signs of Liver Cancer That Could Easily be Missed - Can be 'Vague's
Analyses Show Subgroup-Dependent Benefits of Immunotherapy in HCC
Liver Cancer Rates are Set to Rise Globally by 55% in the Next 2 Decades
July 2023
Hepatitis B and Liver Cancer: Strategies for Prevention and Screening
About 70% of Liver Cancer Deaths Related to Hepatitis
UK Liver Transplantation Allocation Algorithm: Transplant Benefit Score
Radioactive Beads in the Wrist That Can Fight Liver Cancer
Phase 3 RATIONALE-301 Study Evaluates Tislelizumab vs Sorafenib in HCC
First-Line Rivoceranib Plus Camrelizumab Improves Survival in Unresectable HCC
Elevar Touts First-line Potential of Rivoceranib in Phase III Liver Cancer Trial
NHI to Cover Advanced Liver Cancer Treatment
Comparing IMbrave150 and HIMALAYA Outcomes in Frontline HCC
Patients With HCC Often Prioritize QOL Over Survival
Free Tests Identify Liver Issues in 81.4% of Subjects
Lewis Breaks Down the Evolving Treatment Paradigm in HCC
Treatment Approaches for Patients With Early-Stage HCC
Factoring Stage and Hepatic Function Into Treatment Decision-Making for HCC
Overview of Hepatocellular Carcinoma (HCC)
Hepatitis B burden Could Place China at an Elevated Risk of Liver Cancer
HCV Antivirals May Improve Hepatocellular Carcinoma Survival Rates
Treating Hepatitis C ‘Feasible’ in Patients with HCC, Improves Overall Survival
LAMH Receives Chinese Approval for Blood Test Designed to Accelerate Liver Cancer Diagnosis
Understanding Liver Cancer with the Help of Gifts in Wills
Imfinzi-Imjudo Combo Provides Survival Benefit Over 4 Years in Liver Cancer Subset
Spanish Researchers Develop New Immunotherapy Combination for Liver Cancer
June 2023
What to Know About Late-Stage Liver Cancer as a Black Person
New Immunotherapy Combination Improves Efficacy in Animal Models of Liver Cancer
AstraZeneca’s STRIDE Shows Improved Outcomes for Liver Cancer Patients
Webinar Gives Hope for New Liver Cancer Treatments, Clinical Trial Improvements
Dr Lau on the Association of irAEs and OS in the HIMALAYA Study in HCC
Behavioral Data ‘Has the Potential’ to Predict HCC in Patients with Hepatitis B
Treatment With TTI-101 Alone or With Standard Targeted Therapy in Advanced HCC Commences
Phase 2 Evidence on Serplulimab Plus HLX04 in Advanced HCC Calls for Phase 3 Study
Singal Discusses the Importance of Biopsy Testing When Considering HCC Treatment
Education About Liver-Related Diseases is Missing Component
Gene Mutations Linked to Drug-resistant Liver Cancer
AstraZeneca’s Imjudo gets Regulatory Nod as 1st-line Liver Cancer Treatment
£1m Grant to Test Potential Life-saving Liver Cancer Tech
New Strategies for Targeting CTLA-4 Emerge
Sugary Drinks Linked to High Risk of Liver Cancer, Study Finds
Medivir's Patent Application for Fostrox Approved in China
Stereotactic Body Radiotherapy Can Benefit Some Patients with HCC
Tiny Chip for Your Organs Offers New Hope of Treating Deadly Liver Disease
Vaccines to Treat Liver Cancer Part of Project at University of Hawai‘i Cancer Center
Why Men More Susceptible to Liver Cancer than Women
SBRT for Liver Cancer: Practical Techniques and Outcomes
‘Fingerprints’ Point to Liver Cancer Breakthrough
Study Reveals a Trio of Immune Cells Vital in Response to Liver Cancer Immunotherapy
Phase 1b/2a Study of Fostrox Completes Dose-Escalation Portion in HCC
What Can Real-world Evidence Teach us About Atezolizumab plus Bevacizumab in HCC?
CIRM Awards Grant to Support Eureka’s T-cell Therapy Trial
The Connection Between Hepatitis Band Liver Cancer: A Critical Concern
Better Outcomes, No Reduced Safety When Sorafenib Is Preceded by Stereotactic Body RT for HCC
New Biomarker Identified for an Aggressive Type of Liver Cancer
MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery
Tiragolumab Added to Standard of Care Improves Responses in Unresectable Hepatocellular Carcinoma
CNCLD Shares Knowledge of Revolutionary Liver Cancer Treatment with Foreign Doctors
HIMALAYA Safety Data Support STRIDE Regimen as A Global Treatment Option for uHCC
Patients Report no Quality-of-Life Issues with Adjuvant Regimen for High-risk Liver Cancer
Suboptimal Ultrasound Imaging Leads to Higher HCC Risk
May 2023
Egypt at Forefront of Liver Cancer Care with Roche Partnership
VIDEO: Results of IMbrave050 Trial ‘Potentially Practice-Changing’
Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV Screening
Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients
Effects on Patient with HCC on Aspirin During In-Hospital Outcomes
Use of Atezolizumab and Bevacizumab to Treat Advanced HCC
Liver Cancer Is Driven by B Cells
Types of Liver Cancer and Their Symptoms to Watch Out for
Exclusive: 'Fundamental Research is the Key to Making Breakthrough in Liver Cancer'
ASX Health Stocks: Imugene’s liver cancer platform centre stage at prestigious conference
FDA Approval Sought for Frontline Camrelizumab Plus Rivoceranib in uHCC
Elevar Submits New Drug Application for uHCC Combo Therapy
Epigenetic Weakness Identified in Liver Cancer May Lead to Improved Treatment
Dr Goff on the Investigation of Adjuvant Atezolizumab Plus Bevacizumab in HCC
Advancing the Care of Advanced HCC – A Hepatologist’s Perspective
Significant Drop in Hepatocellular Carcinoma Cases Reported in 2020 vs. Pre-COVID Years
Researchers Review the Role of Integrins in Human Hepatocellular Carcinoma
Adjuvant Atezolizumab and Bevacizumab Delays Recurrence in Early-Stage HCC
New Drug Delivery System Delivers Antioxidant Directly to Mitochondria in the Liver
Herbal Teas to Help Your Liver
Study Shows Interferon-based Treatment of Hep C in Japan Reduced Hepatocellular Carcinoma Occurence
VIDEO: Circulating Tumor DNA Levels Could Help Predict Hepatocellular Carcinoma Recurrence
Study Finds Higher Rates of Liver Cancer, Low Birthweights Near Toxic Site in Northeast Wichita
Etiology Plays Role in Outcomes of Frontline HCC Trials
Dr. Noonan on Challenges Regarding the Sequencing and Selection of Therapies in HCC
Liver Cancer 'Red Flag' Warning Signs as Subtle Symptoms Across Body Can Go Unnoticed
Novel Liver Cancer Drug Shows ‘Promising’ Improvements HCC
Efficacy and Safety of Nivolumab Plus Cabozantinib, with or without Ipilimumab, in Advanced HCC
Phase 1b/2 Study of TPST-1120 Generates Encouraging Data in First-Line HCC
Blood Biomarkers for HCC: End of Ultrasound Era?
Upstate Researcher Discovers Link Between Artificial Sweeteners and Liver Cancer
April 2023
Phase 3 Study of Camrelizumab/Rivoceranib Improves PFS and OS Rates in HCC
Microvascular Invasion in Hepatocellular Carcinoma: Can a CT Radiomics Model Have an Impact?
Ajou Researchers Find How to Tackle TKI Resistance in Liver Cancer
AACR 2023 Highlights on Advances in the Treatment of Hepatocellular Carcinoma with Pierce Chow
Combo Therapy May Prevent Cancer's Return After Liver Surgery
Durvalumab/Tremelimumab for HCC in Patients Undergoing Liver Transplant
Liver Cancer: Treatment Depends on Patient’s Stage and Age
About the LEAP-002 Trial of Lenvatinib With/Without Pembrolizumab in uHCC
World Liver Day: Reason For High Prevalence Of Liver Cancer In Northeast India
Liver Cancer Rates are Surging in Australia – and Climate Change Could be to Blame
Explained: World Liver Day: Is Liver Disease Hereditary? Here Is What Experts Say
Liver Cancer Symptoms: 5 Warning Signs Of Hepatocellular Carcinoma That Should Never Be Ignored
THE USE OF BEVACIZUMAB IN MANAGING ADVANCED HCC: PHYSICIAN PERSPECTIVES
MAIA Biotechnology Announces Excellent Efficacy of THIO in Liver Cancer Models
5 Things to Know about Liver Cancer
Roche Reports Positive Phase 3 Data for Tecentriq Combination in Liver Cancer
Shanghai Announces Data from Phase I Trial of C-CAR031 in Advanced HCC
Multidisciplinary Decision Making in Advanced HCC: An Interventional Radiologist’s Perspective
Kinase Inhibitors Remain Reliable, but Newer Targeted Agents Push OS and PFS Rates in HCC
What’s New in Treating Hepatocellular Carcinoma, the Most Common Liver Cancer?
Genetic Signature Discovery May Revolutionize Liver Cancer Diagnosis and Monitoring
Curtin Researchers Identify the Genetic Signature of Pre-Malignant Liver Cells
Harnessing ChatGPT to Improve Liver Disease Outcomes
New Study Flips the Script on Liver Cancer
Blue Faery Grants Award for Liver Cancer Research
CRISPR Used to Identify Genetic Mutations Responsible for Liver Cancers
Diets Promoting Inflammation, Hyperinsulinemia May Increase Risk of HCC
Ablaze Pharmaceuticals to Develop Drug Candidate for Liver Cancer
Georgia System Among 1st to Offer Y90 Liver Cancer Treatment to Pediatric Patients
Data-Sharing Collaboration Aims to Advance Cancer Prevention
March 2023
Novel Use of Artificial Intelligence Shows Promise to Improve HCC Detection
Nivolumab Plus Cabozantinib Shows Early Promise in Advanced HCC
Multidisciplinary Decision Making in Advanced HCC: An Oncologist’s Perspective
NRG/RTOG 1112 Study Evaluates SBRT Plus Sorafenib for Hepatocellular Carcinoma
Factors that impact your liver cancer mortality
Key Factors for Choosing Frontline Hepatocellular Carcinoma Therapy
New Tests Seek to Predict Liver Cancer Relapse and Improve Survival Rates
NHS Launches new Initiative to Check for Cancer in High-risk Communities
Finn Reviews Phase 3 Trials of Lenvatinib in Advanced HCC
Scientists Reveal a Potential New Approach to Treating Liver Cancer
Dr. Hwang on First-line Treatment Options in HCC
AI Could Develop Cancer Treatments in Less Than a Month
NHS Sending out Trucks to Scan People for Liver Cancer Risk
NHS On-the-Spot Liver Scans Identify Hundreds at Risk of Cancer
Dr. Ahn on the Evolution of First-line Treatment Options in HCC
Dr. Ahn on the Selection of First-line ICI-Based Combinations in HCC
Selecting the Appropriate Frontline Treatment in Advanced HCC
FDA Grants Orphan Drug Designation to YB-200 for Hepatocellular Carcinoma
Indian Scientists Discover Seagrass has Potential to Cure Liver Cancer
Determining Need for Biopsy in Suspected Hepatocellular Carcinoma
Pelvic CT After Liver Cancer: Costs Versus Benefits
Advanced Liver Cancer, New Therapy Approved in Europe
February 2023
KASU, Danfodio Varsity Scientists Get Grant For Liver Cancer Treatment
Current Perspectives on the BCLC Staging System for Hepatocellular Carcinoma
EU Approves Durvalumab/Tremelimumab Combo for Advanced Lung, Liver Cancers
Subsequent-Line Treatment Options for Hepatocellular Carcinoma With Progression: ASCO 2023
Estimation of HCC Risk in HIV/HBV Patients Using PAGE-B Score
Patients With Intermediate Stage HCC Unsuitable for TACE
Medivir has Determined the Recommended Phase 2 Dose for Fostrox in Combination with Lenvima in HCC
'Liver Transplant Candidates' Often Report One of Two Symptoms on Their Tongue - Study
Marijuana Use Not Linked to Worse Outcomes After a Liver Transplant
Iron-Dependent Cell Death Could Unlock New Liver Cancer Treatments
Hepatic Resection Linked With Better OS After RT+TACE for HCC With MVI
Sorafenib Plus SBRT Shows Improvement in QOL Measure for HCC
Hollings Awards Pilot Project Funding to Jumpstart Cancer Research Projects
Study Suggests Antibody Therapy Can be Used to Treat Liver Disease
What Are The Best Options Available For Liver Cancer Treatment?
Liver Cancer On A Rise In India: Here Are Some Ways To Reduce Your Risk
First-line Treatment for Advanced HCC with Lentivinib & Transarterial Chemoembolization
Q BioMed chemotherapy Uttroside B for liver cancer to get US patent
The World Needs Garp, According to Abbvie
Liver Cancer: Know About Risk Factors Behind Hepatocellular Carcinoma
Robotic Surgery for HCC is Safe and Effective, Study Finds
FDA Grants Orphan Drug Designation to Ezurpimtrostat for HCC
‘Old or Young, Liver Cancer Patients Should Positively Get Treatment’
Genoscience Pharma Receives Orphan Drug Designation for Hepatocellular Carcinoma Drug
NRG/RTOG 1112 Trial Highlights Benefit of Adding SBRT to Sorafenib in Locally Advanced HCC
HCC International Clinical Trials
HLB’s Rivoceranib Combo Therapy Wins Chinese Permit for Liver Cancer
SBRT Plus Sorafenib Improves Survival in Locally Advanced HCC
Sintilimab Plus Bevacizumab Biosimilar Improved Response in Unresectable HCC
Liver cancer treatment costly for Medicare patients, UT Southwestern study finds
Large VA Trial Could Change How Patients are Screened for Liver Cancer
January 2023
Sintilimab Plus Bevacizumab Biosimilar Improved Response in Unresectable HCC
Analysis Reveals That Cost of Treating Liver Cancer Might be Very High for People
Netris Pharma Starts Hepatocellular Carcinoma Study
Immune Checkpoint Inhibitors and Their Effects on Liver Function
Abbreviated MRI and Early-Stage Hepatocellular Carcinoma: What a New Multicenter Study Reveals
New 3D Ultrasound may Improve Accuracy of Liver Cancer Treatment
Milwaukee VA to Take Part in Nation’s Largest Liver Cancer Screening Study
Ants can 'Sniff Out' Cancer in Urine, Scientists Find
Radiation Therapy Reduces Pain in Advanced Hepatocellular Carcinoma
Lawmakers Announce Bills That Would Crack Down on ‘Forever Chemicals’ Made by 3M
First Application of AlphaFold in Identifying Potential Liver Cancer Drug
Stereotactic Body Radiation Extends Survival in Hepatocellular Carcinoma
Lenvima May Prolong Survival in Advanced Liver Cancer That Progressed on Immunotherapy
Newer Therapies Demonstrate Real-world Benefit Vs Sorafenib in First-line HCC
Dr. Dawson on the Addition of SBRT to Sorafenib in Locally Advanced HCC
Envafolimab Combo Yields Efficacy and Safety in Liver Cancer Subtype
New Therapy Improves Intermediate Liver Cancer Cure Rate by 55 Percent
Lenvatinib Following Progression on Immunotherapy Demonstrates Efficacy in Second-line HCC
Pembrolizumab Combo Produces Comparable QOL Vs Lenvatinib in Liver Cancer Subtype
Contrast-enhanced CT Enables Prediction of Treatment Response in Liver Cancer
Anti-drug Antibodies Do Not Affect Durvalumab Alone, With Tremelimumab in Unresectable HCC
Durvalumab±Tremelimumab Efficacy Does Not Seem Affected by ADAs in Hepatocellular Carcinoma
New Study Uses AlphaFold and AI to Accelerate Design of Novel Drug for Liver Cancer
Adjuvant Atezolizumab Plus Bevacizumab Improve RFS in Early-Stage Hepatocellular Carcinoma
Combination Therapy with Immune Checkpoint Inhibitors for HCC
Roche : Phase III Study Of Tecentriq Combination In Hepatocellular Carcinoma Meets Primary Endpoint
Health Talk: Preventing Liver Cancer and Viral Hepatitis—What You Need to Know
Roche's Tecentriq to be Filed for Early-stage Liver Cancer
Charles River Inks Gene Therapy Development and Manufacturing Pact with South Korean Biopharma
Phase 3 HIMALAYA Trial Shows OS Benefit of Durvalumab in HCC
Potential Treatment Target for Childhood Liver Cancer Identified
Diet Packed With Fast Food Is Hard on the Liver
Demographics Factor in Heavily for Patients With Advanced HCC
Significance of Lenvatinib/Pembrolizumab Vs Lenvatinib Outcomes in HCC
RBMY Mediated HCC Metastasis for PIM1-Induced Cytoplasmic Expression
New Liver Cancer Surveillance Guidelines to ‘Fill Gap in Prevention’
Treatment and Outcomes for Patients with Hepatocellular Carcinoma Treated at a Single Center
Treatment Paradigm of Advanced HCC Displays Exciting Growth in the First and Later Lines
Novel Anti-HCC Agent Shows Efficacy and Safety in Liver Cancer Xenografts
The Advent of Systemic Therapy for HCC
Algorithm Helps Identify Best Treatment for Recurrent Hepatocellular Carcinoma
Liver Cancer Cells Hijack Mutated Circadian Clock Proteins to Grow and Spread
HKU Develops New Treatment for Liver Cancer
Phase 3 Study of Camrelizumab/Rivoceranib Improves Survival vs Sorafenib in HCC
A Silent Killer, Liver Cancer Prompts Race to Improve Organ Replacements
Nancy Reau, MD: Concerns Over the Increase in Liver Disease
Review Focuses on the Link Between the Pathogenesis and Management of Hepatocellular Carcinoma
Long-term Risk of HCC After SVR Using FIB-4
UNMC Researcher Tracks Changing Liver Cancer Trends
Japan Approves Durvalumab/Tremelimumab Combo for HCC and Advanced NSCLC
KEYNOTE-394: Pembrolizumab as Second-Line Therapy in Asian Patients With Advanced HCC
Liver Cancer Awareness – Here’s What You Need to Know in 2023
Liver Cancer Manipulates Internal Clock to Spread: Study
HAIC-Administered FOLFOX Lengthens DFS and Provides a Tolerable Safety Profile in HCC
Mapping Lactylome in Hepatocellular Carcinoma Reveals New Mechanisms of Metabolic Adaptation
Robotic Liver Resection for HCC Reduced Length of Hospital Stay, ICU Admissions
EMA’s CHMP Gives Positive Opinion for Durvalumab/Tremelimumab Combo in Liver and Lung Cancer
China Accepts BeiGene's Supplemental License Application for Treatment of Liver Cancer